This paper discusses disadvantages and limitations of the available inferential approaches in sequential clinical trials for treatment comparisons managed via response-adaptive randomization. Then, we propose an inferential methodology for response-adaptive designs which, by exploiting a variance stabilizing transformation into a bootstrap framework, is able to overcome the above-mentioned drawbacks, regardless of the chosen allocation procedure aswell as the desired target.We derive the theoretical properties of the suggested proposal, showing its superiority with respect to likelihood, randomization and design-based inferential approaches. Several illustrative examples and simulation studies are provided in order to confirm the re...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
We consider a problem of reducing the expected number of treatment failures in trials where the prob...
Clinical trial seek to investigate novel treatments, asses the relative benefits of competing therap...
This paper discusses disadvantages and limitations of the available inferential approaches in seque...
The present paper discusses drawbacks and limitations of likelihood-based inference in sequential c...
This book addresses the issue of designing experiments for comparing two or more treatments, when th...
PhDPrevious work on two-treatment comparisons has shown that the use of optimal response-adaptive r...
Response-adaptive (RA) allocation designs can be implemented in clinical trials to skew the allocati...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
In recent years, adaptive designs in clinical trials have been attractive due to their efficiency an...
Response-adaptive designs have been proposed in randomized clinical tri- als to achieve ethical adva...
Stein's method introduced by Charles Stein (1972) is a powerful tool in distributional approximatio...
We discuss methods for comparing effects of two treatments A and B. We investigate the performance ...
Clinical trials are complicated and involve human beings. Therefore, lots of ethical and efficient o...
In this paper we provide some general asymptotic properties of covariate-adaptive (CA) randomized de...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
We consider a problem of reducing the expected number of treatment failures in trials where the prob...
Clinical trial seek to investigate novel treatments, asses the relative benefits of competing therap...
This paper discusses disadvantages and limitations of the available inferential approaches in seque...
The present paper discusses drawbacks and limitations of likelihood-based inference in sequential c...
This book addresses the issue of designing experiments for comparing two or more treatments, when th...
PhDPrevious work on two-treatment comparisons has shown that the use of optimal response-adaptive r...
Response-adaptive (RA) allocation designs can be implemented in clinical trials to skew the allocati...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
In recent years, adaptive designs in clinical trials have been attractive due to their efficiency an...
Response-adaptive designs have been proposed in randomized clinical tri- als to achieve ethical adva...
Stein's method introduced by Charles Stein (1972) is a powerful tool in distributional approximatio...
We discuss methods for comparing effects of two treatments A and B. We investigate the performance ...
Clinical trials are complicated and involve human beings. Therefore, lots of ethical and efficient o...
In this paper we provide some general asymptotic properties of covariate-adaptive (CA) randomized de...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
We consider a problem of reducing the expected number of treatment failures in trials where the prob...
Clinical trial seek to investigate novel treatments, asses the relative benefits of competing therap...